In those rare cases of particularly intense and/or persistent GI AEs, HCPs can apply further measures (Figure 4): If GI AEs appear during the dose-escalating phase, HCPs could modify the planned schedule by implementing one or several of the following points [35,36]: Extend the dose escalation phase duration (24 more weeks with the previous dose or temporary suspension)
Cost expectations and clinical trial access If it clears approval, retatrutide will probably price out near tirzepatide and semaglutide, somewhere around CAD 400 to 600 a month at retail, with insurance likely following the same path as the other obesity drugs
Tirzepatid (Mounjaro) virker p to: GLP-1 og GIP
If you have chronic kidney disease, liver disease, or are taking medications that affect kidney or liver function, your provider may need to adjust the pyridoxine dose in your compound or monitor B6 levels more frequently
BPOMs approved Wegovy material makes that clear
Hypertension 60 , 757764 (2012)
)
